ORIC Oric Pharmaceuticals, Inc.

8-K Current Report

Filed: February 23, 2026

Health Care

Pharmaceutical Preparations

Oric Pharmaceuticals, Inc. (ORIC) 8-K current report filed with SEC EDGAR on February 23, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• New $200M ATM offering launched Feb 26, 2026 via Jefferies; replaces prior $200M 2024 program now closed
• Prior ATM sold 13.48M shares for ~$139.7M gross proceeds, implying ~$10.37/share avg sale price

+2 more insights

Other Oric Pharmaceuticals, Inc. 8-K Filings

8-K Feb 23, 2026

Get deeper insights on Oric Pharmaceuticals, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.